From Casetext: Smarter Legal Research

In re Zostavax Zoster Vaccine Live Prods. Liab. Litig.

United States District Court, E.D. Pennsylvania
Oct 11, 2023
MDL 2848 (E.D. Pa. Oct. 11, 2023)

Opinion

MDL 2848 CIVIL ACTION 18-20020

10-11-2023

IN RE ZOSTAVAX ZOSTER VACCINE LIVE PRODUCTS LIABILITY LITIGATION THIS DOCUMENT RELATES TO: JOSEPH BOCKUS v. MERCK & CO., INC., et al.


PRETRIAL ORDER NO. 508

Harvey Bartle III, J.

AND NOW, this 11th day of October 2023, for the reasons set forth in the foregoing Memorandum, it is hereby ORDERED that the motion of defendants Merck & Co., Inc. and Merck Sharp & Dohme Corp. insofar as it seeks to exclude the general causation opinions of Mark Poznansky, M.D. and David Saperstein, M.D. (MDL Doc. # 1230) is DENIED, but the motion of defendants insofar as it seeks to exclude the specific causation opinion of David Saperstein, M.D. is GRANTED.


Summaries of

In re Zostavax Zoster Vaccine Live Prods. Liab. Litig.

United States District Court, E.D. Pennsylvania
Oct 11, 2023
MDL 2848 (E.D. Pa. Oct. 11, 2023)
Case details for

In re Zostavax Zoster Vaccine Live Prods. Liab. Litig.

Case Details

Full title:IN RE ZOSTAVAX ZOSTER VACCINE LIVE PRODUCTS LIABILITY LITIGATION THIS…

Court:United States District Court, E.D. Pennsylvania

Date published: Oct 11, 2023

Citations

MDL 2848 (E.D. Pa. Oct. 11, 2023)